Personalized Health Association (PHA) Launches to Expand Access to Personalized and Precision Healthcare Nationwide
The launch announcement PHA issued on November 24, 2025, naming the coalition behind it and its founding focus on physician autonomy and patient access.
FOR IMMEDIATE RELEASE
Washington, D.C. — November 24, 2025
The Personalized Health Association (PHA) today announced its official launch as a federally registered 501(c)(4) advocacy organization dedicated to advancing access to personalized, precision, preventive, longevity-focused, and regenerative healthcare across the United States.
PHA unites a broad coalition of leaders shaping the next era of American longevity and preventative medicine, including telemedicine providers; compounding pharmacies; peptide, stem-cell, and API manufacturers; nutraceutical and healthspan innovators; diagnostics and biomarker firms; drug-delivery device companies; and wearable and digital-health technology companies.
Founder's Statement
"The personalized health ecosystem is advancing at an accelerating pace. PHA was created to strengthen physician autonomy, protect patient access to individualized therapies, and ensure innovative, prevention-focused healthcare can scale responsibly. Our goal is to build the credible, unifying voice this industry needs as it moves into the mainstream." — Bill Moses, Founder & Chairman, Personalized Health Association
Leadership Statements
Jimmy St. Louis, President of PHA:
"Across regenerative medicine, telehealth, and longevity, patients are seeking options that traditional healthcare systems have been too slow to provide. PHA exists to protect access to these emerging therapies while upholding the standards, safety, and scientific rigor our industry deserves."
Lee Rosebush, Lead Strategic Advisor & Chairman of the Outsourcing Facilities Association (OFA):
"The regulatory environment surrounding peptides, compounded therapies, and emerging modalities is evolving faster than ever. PHA ensures our community's voice is part of the process so policy strengthens access, safety, and innovation rather than restricting it."
Emily Kaplan, Strategic & Communications Advisor:
"Policymakers and the public are trying to make sense of a rapidly evolving field. PHA provides a trusted platform to explain what's real, what's safe, and what's possible—ensuring the conversation is grounded in evidence and guided by responsible innovation."
Policy Focus
Through coordinated policy engagement, public education, and multi-stakeholder collaboration, PHA will work to ensure that fast-moving healthcare innovations are understood, responsibly regulated, and accessible to the millions of Americans who stand to benefit.
This includes advocating for:
- Modernized provider networks
- Physician autonomy
- Patient access to individualized therapies
- Best-practice frameworks for emerging modalities
- Evidence-based communication
About the Personalized Health Association (PHA)
The Personalized Health Association (PHA) is a federally registered 501(c)(4) advocacy organization uniting innovators transforming American healthcare through regenerative, personalized, and precision medicine. Its coalition spans telemedicine providers; compounding pharmacies; peptide and API manufacturers; nutraceutical and longevity innovators; diagnostics and biomarker firms; specialty medical-technology firms; and wearable and digital-health platforms.
PHA works to expand access to individualized therapies, defend physician autonomy, and advance a healthcare system built on prevention, personalization, and patient empowerment.